2642235-06-9
2642235-06-9
Chemical Structure
BAY-2925976
- CAS No.: 2642235-06-9
- Formula:C21H27F2N5OS
- Molecular Weight:435.53
InChIKey: MUEUIRFXUWDRNF-CQSZACIVSA-N
SMILES: C[C@@H]1CCCN(C2CCN(C3=NC=C(C(NCC4=C(F)C=C(F)C=N4)=O)S3)CC2)C1
Biological Activity: BAY-2925976 is an ARα2C antagonist. BAY-2925976 acts on G protein-coupled presynaptic autoreceptors and inhibits norepinephrine release at low endogenous norepinephrine concentrations. BAY-2925976 can be used in research on obstructive sleep apnea (OSA)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BAY-2925976 | 99.14% | BAY-2925976 is an ARα2C antagonist. BAY-2925976 acts on G protein-coupled presynaptic autoreceptors and inhibits norepinephrine release at low endogenous norepinephrine concentrations. BAY-2925976 can be used in research on obstructive sleep apnea (OSA). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
